Zeiss

New strategies to assess the risk of diabetes-related vision lossA colleague recently told me that eye doctors should “stay within the lines” of traditional eye care because we barely have enough time as it is to do our jobs. My response was that today more than half of our adult patients have either diabetes or prediabetes, so our job now requires we go ”outside the lines” to avoid the leading cause of preventable blindness.
Offer options to your cataract patientsAs primary-care optometrists, we are the gatekeepers for baby boomers inquiring about cataract surgery. Today’s patients have treatment options available not only to address their lifestyle complaints but to provide them with better vision and possibly reduced dependence on glasses or contact lenses.
3 ways to reassess your goals heading into Q4As summer winds down and the holidays begin to come into focus, it’s beneficial to take time to reevaluate the goals we set forth months prior. It’s time to take a look at how we’ve progressed in accomplishing them.
Comparing PCO and glistenings in 2 hydrophobic IOLs: 3-year resultsIn this article, Dr Johannson presents intraindividual IOL comparison follow-up results. Although similar levels of PCO development were observed for both AcrySof and Tecnis one-piece IOLs, fewer glistenings appeared in the Tecnis material, 3 years after implantation.
New digital lens targets millennialsZeiss has unveiled a new product—Zeiss Digital Lens—that targets the vision needs of the millennial generation. The company will also launch a consumer marketing approach designed to raise awareness and drive demand for the product.
Zeiss broadens portfolio of IOLsCarl Zeiss Meditec AG has acquired—through its subsidiary Carl Zeiss Meditic Inc.—100% of the shares in Aaren Scientific Inc., a US-based manufacturer of IOLs.